node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
CG10209 | CG10949 | FBpp0302918 | FBpp0312085 | Uncharacterized protein, isoform B; CG10209 encodes a DNA binding nuclear apoptosis-inducing factor involved in the apoptotic process. | GH22016p; It is involved in the biological process described with: regulation of transcription by RNA polymerase II. | 0.579 |
CG10209 | CG6340 | FBpp0302918 | FBpp0073856 | Uncharacterized protein, isoform B; CG10209 encodes a DNA binding nuclear apoptosis-inducing factor involved in the apoptotic process. | GH25653p. | 0.692 |
CG10949 | CG10209 | FBpp0312085 | FBpp0302918 | GH22016p; It is involved in the biological process described with: regulation of transcription by RNA polymerase II. | Uncharacterized protein, isoform B; CG10209 encodes a DNA binding nuclear apoptosis-inducing factor involved in the apoptotic process. | 0.579 |
CG10949 | CG6340 | FBpp0312085 | FBpp0073856 | GH22016p; It is involved in the biological process described with: regulation of transcription by RNA polymerase II. | GH25653p. | 0.553 |
CG1622 | CG4119 | FBpp0073588 | FBpp0309405 | FI05227p; It is involved in the biological process described with: mRNA splicing, via spliceosome. | BcDNA.LD23634; mRNA binding. It is involved in the biological process described with: regulation of alternative mRNA splicing, via spliceosome; mRNA splicing, via spliceosome. | 0.791 |
CG1622 | CG6340 | FBpp0073588 | FBpp0073856 | FI05227p; It is involved in the biological process described with: mRNA splicing, via spliceosome. | GH25653p. | 0.526 |
CG4119 | CG1622 | FBpp0309405 | FBpp0073588 | BcDNA.LD23634; mRNA binding. It is involved in the biological process described with: regulation of alternative mRNA splicing, via spliceosome; mRNA splicing, via spliceosome. | FI05227p; It is involved in the biological process described with: mRNA splicing, via spliceosome. | 0.791 |
CG4119 | CG6340 | FBpp0309405 | FBpp0073856 | BcDNA.LD23634; mRNA binding. It is involved in the biological process described with: regulation of alternative mRNA splicing, via spliceosome; mRNA splicing, via spliceosome. | GH25653p. | 0.843 |
CG4119 | Caper | FBpp0309405 | FBpp0088579 | BcDNA.LD23634; mRNA binding. It is involved in the biological process described with: regulation of alternative mRNA splicing, via spliceosome; mRNA splicing, via spliceosome. | Caper, isoform A; Caper (Caper) encodes an RNA-binding protein involved in regulation of alternative mRNA splicing. | 0.813 |
CG4119 | Ythdc1 | FBpp0309405 | FBpp0072940 | BcDNA.LD23634; mRNA binding. It is involved in the biological process described with: regulation of alternative mRNA splicing, via spliceosome; mRNA splicing, via spliceosome. | YTH domain-containing protein 1; Regulator of alternative splicing that specifically recognizes and binds N6-methyladenosine (m6A)-containing RNAs. Acts by acting as a reader of m6A methylation. Required for sex determination and dosage compensation via Sxl alternative splicing: m6A methylation acts as a key regulator of Sxl pre-mRNA and promotes female-specific alternative splicing of Sxl, which determines female physiognomy. M6A methylation is also required for neuronal functions. | 0.698 |
CG6340 | CG10209 | FBpp0073856 | FBpp0302918 | GH25653p. | Uncharacterized protein, isoform B; CG10209 encodes a DNA binding nuclear apoptosis-inducing factor involved in the apoptotic process. | 0.692 |
CG6340 | CG10949 | FBpp0073856 | FBpp0312085 | GH25653p. | GH22016p; It is involved in the biological process described with: regulation of transcription by RNA polymerase II. | 0.553 |
CG6340 | CG1622 | FBpp0073856 | FBpp0073588 | GH25653p. | FI05227p; It is involved in the biological process described with: mRNA splicing, via spliceosome. | 0.526 |
CG6340 | CG4119 | FBpp0073856 | FBpp0309405 | GH25653p. | BcDNA.LD23634; mRNA binding. It is involved in the biological process described with: regulation of alternative mRNA splicing, via spliceosome; mRNA splicing, via spliceosome. | 0.843 |
CG6340 | CG8675 | FBpp0073856 | FBpp0074220 | GH25653p. | CG8675-PA. | 0.840 |
CG6340 | CG9890 | FBpp0073856 | FBpp0071893 | GH25653p. | LD46465p; Nucleic acid binding. | 0.671 |
CG6340 | Caper | FBpp0073856 | FBpp0088579 | GH25653p. | Caper, isoform A; Caper (Caper) encodes an RNA-binding protein involved in regulation of alternative mRNA splicing. | 0.608 |
CG6340 | Ythdc1 | FBpp0073856 | FBpp0072940 | GH25653p. | YTH domain-containing protein 1; Regulator of alternative splicing that specifically recognizes and binds N6-methyladenosine (m6A)-containing RNAs. Acts by acting as a reader of m6A methylation. Required for sex determination and dosage compensation via Sxl alternative splicing: m6A methylation acts as a key regulator of Sxl pre-mRNA and promotes female-specific alternative splicing of Sxl, which determines female physiognomy. M6A methylation is also required for neuronal functions. | 0.653 |
CG6340 | eIF3d1 | FBpp0073856 | FBpp0088565 | GH25653p. | Eukaryotic translation initiation factor 3 subunit D-1; mRNA cap-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is involved in protein synthesis of a specialized repertoire of mRNAs and, together with other initiation factors, stimulates binding of mRNA and methionyl-tRNAi to the 40S ribosome. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation. In the eIF-3 complex, eif3d specifically recognizes and binds the 7- methylguanosine cap of a subset of mRNAs. | 0.489 |
CG6340 | ytr | FBpp0073856 | FBpp0072143 | GH25653p. | Yantar, isoform A; Yantar (ytr) encodes a conserved arginine-rich protein involved in alternative splicing and hemocyte differentiation. | 0.844 |